06 October 2010 14:21 [Source: ICIS news]
TORONTO (ICIS)--Monsanto’s fiscal 2010 net income fell by $1bn (€720m), or 47%, to $1.1bn as overall sales dropped 10% due to a weak performance in the company’s agricultural segment, the ?xml:namespace>
Net sales for the 12 months ended 31 August were $10.5bn, compared with $11.7bn in the 2009 fiscal year. Seeds and genomics segment sales rose slightly but sales in Monsanto’s agricultural productivity segment declined 35%.
“Pricing actions for Roundup and other glyphosate-based herbicides had a significant effect on overall net sales and gross profit,” the company added.
Full-year gross profit was $5.08bn, compared with $6.76bn in the 2009 fiscal year.
For the fiscal fourth quarter ended 31 August, Monsanto recorded a net loss of $143m, compared with a net loss of $233m in the year earlier period, as overall fourth-quarter sales rose 4% to $1.95bn.
In its outlook, Monsanto said that its seeds and genomics segment, “which will account for the bulk of Monsanto's business in fiscal year 2011 and beyond”, was expected to deliver single-digit unit volume growth. Seed and genomics already accounted for over 70% of fiscal 2010 net sales.
Fiscal 2011 earnings per share from ongoing business were expected to increase by 13-17%, to a range of $2.72 to $2.82, Monsanto said.
This compares with fiscal 2010 and fiscal 2009 earnings per share from ongoing business of $2.41 and $4.41, respectively.
($1 = €0.72)
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|